Advenchen Laboratories, LLC   Report issue

For profit Phase 2 Phase 3
Founded: Moorpark CA United States (2003)

Organization Overview

First Clinical Trial
2015
NCT02558348
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Advenchen Laboratories, LLC | Advenchen Laboratories Nanjing Ltd.